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Some inactive precursor proteins, or zymogens, contain small, amino terminus, homopolymeric regions of
Asp that neutralize the cationic charge of the active protein during synthesis. After posttranslational cleavage,
the anionic propeptide fragment may exhibit antimicrobial activity. To demonstrate this, ovine trypsinogen
activation peptide, and frog (Xenopus laevis) PYL activation peptide, both containing homopolymeric regions of
Asp, were synthesized and tested against previously described surfactant-associated anionic peptide. Peptides
inhibited the growth of both gram-negative (MIC, 0.08 to 3.00 mM) and gram-positive (MIC, 0.94 to 2.67 mM)
bacteria. Small, anionic, and charge-neutralizing propeptide fragments of zymogens form a new class of
host-derived antimicrobial peptides important in innate defense.
Many defensins, hormones, and enzymes are synthesized as
inactive precursor proteins, called zymogens. Zymogens con-
sist of an amino terminus-inactivating prefix peptide (called a
propeptide) followed by the active portion of the protein mol-
ecule (18). The propeptide fragment serves to prevent prema-
ture physiologic function of the active portion of the protein,
thus protecting host cells from cytotoxic or enzymatic damage
during enzyme synthesis and secretion (16, 18). For activation,
zymogens are posttranslationally cleaved in a region amino
terminal relative to the active site of the protein either before
intracellular release of defensin into phagolysosomes (16) or
before extracellular release of enzyme or hormone (18). While
the synthesis, secretion, and activation mechanisms of these
particular proteins have been well described (18), the fate and
activity of the cleaved propeptide fragments are unknown in
most instances (18). Some zymogen fragments have additional
physiological functions in cascade reactions (e.g., peptides
cleaved from complement and prothrombin [18, 27]) or in
innate defense mechanisms (e.g., antimicrobial activity of gas-
tric inhibitory polypeptide and diazepam-binding polypeptide
[1]). The dual role of peptide fragments in innate host immu-
nity has been proposed (3).
Some propeptide fragments of zymogens contain homopoly-
meric regions of Asp. These anionic regions in the propeptide
fragment are conserved among a number of animal species (7,
18), as well as among a number of enzymes, hormones, and
cationic proteins within an animal species. Recently, we iso-
lated three small (721.6- to 823.8-Da), anionic peptides (called
surfactant-associated anionic peptides or SAAP) from sheep
pulmonary surfactant (6). These peptides inhibited the growth
of both gram-negative and gram-positive bacteria in 0.14 M
NaCl with 2.5 mM ZnCl2. Antimicrobial activity resided in the
core Asp hexapeptide homopolymeric region, and growth in-
hibition by a number of analogs increased with the number of
Asp residues in the peptides (6). The amino acid sequences of
SAAP are similar to those of charge-neutralizing activation
peptides of Group I serine proteases (e.g., ovine trypsinogen
activation peptide or TAP) (7, 18), some prohormones (e.g.,
frog [Xenopus laevis] PYL activation peptide [4, 12]), and pro-
defensins (16) and contain homopolymeric regions of Asp fol-
lowing a Gly or Ala terminating with Lys (Fig. 1). Preliminary
work has shown that SAAP have a genetic basis of origin and
may be propeptide fragments of a larger endogenous protein,
heretofore unknown. Phage inserts, cloned from a degenerate
nucleotide SAAP probe of a genomic sheep library, contained
nucleotide sequences from which were derived predicted
amino acid sequences of these homopolymeric Asp regions
following Gly or Ala which appear to be only part of a much
larger gene product. We propose that SAAP and similar small
anionic propeptide fragments of zymogens (4, 10, 12, 16, 18)
have innate immune functions in addition to their charge-
neutralizing roles. While the antimicrobial activity of SAAP
has been previously described (6), the antimicrobial activities
of similar propeptide fragments have not. Therefore, the pur-
pose of this study was to examine the antimicrobial activities of
two representative synthetic propeptide fragments, ovine TAP
and frog (X. laevis) PYL activation peptide, and to compare
their activities with that of SAAP. Analogs of TAP and SAAP
were also synthesized to assess the effect of peptide composi-
tion on antimicrobial activity.
SAAP (6), ovine TAP (7), and the propeptide fragment of
hormone PYL from frog (X. laevis) skin (e.g., H-ADAD
DDDDK-OH, starting 6 amino acids from the NH2-terminal
cleavage site for signal peptidase and immediately prior to the
24-amino-acid sequence for PYL [12]) were synthesized by
Chiron Mimotopes Peptide Systems, San Diego, Calif., on a
grafted polymer surface in a Multipin peptide synthesis format
with N-alpha-Fmoc-protected amino acids. Side-chain depro-
tection and cleavage were carried out by acidolysis.
Peptides were purified on a Vydac (protein) C4 column
(0.46 cm by 25 cm; 4-mm particle size; 300-Å core size). Frac-
tions, in 0.1% (vol/vol) orthophosphoric acid in water, were
eluted over 15 min with a 0 to 100% gradient of 0.1% (vol/vol)
orthophosphoric acid in 60% (vol/vol) acetonitrile in water.
Mass spectrometer analysis was performed with a Perkin-
Elmer Sciex API III mass spectrometer having an ionspray ion
source with ion-counting detection. Peptides were 95 to 99%
pure. Analogs of TAP and SAAP (i.e., H-GDDDDDD-OH,
H-ADDDDDD-OH, H-GADDDDD-OH, H-AADDDDD-
* Corresponding author. Mailing address: Respiratory and Neuro-
logic Disease Research Unit, USDA, ARS, National Animal Disease
Center, 2300 Dayton Rd., P.O. Box 70, Ames, IA 50010. Phone: (515)
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OH, H-DDDDK-OH, and H-GDDDK-OH) were similarly
prepared.
A panel of conventional gram-negative bacteria (Klebsiella
pneumoniae ATCC 10031, Escherichia coli ATCC 12795,
Pseudomonas aeruginosa ATCC 27312, and Serratia marcescens
ATCC 14756) and gram-positive bacteria (Staphylococcus au-
reus ATCC 29213 and Streptococcus faecalis ATCC 29212)
were used. Pasteurella haemolytica serotype A1 strain 82-25,
isolated from a sheep with enzootic pneumonia, was also in-
cluded since both SAAP and TAP are of sheep origin and
nearly identical in composition (6, 7). A nonpathogenic eucary-
otic organism, Candida krusei ATCC 6258, was also used. All
cultures were grown in tryptose broth at 37°C for 3 h, pelleted
by centrifugation at 5,900 3 g for 15 min at 4°C, and resus-
pended in 0.14 M NaCl. The suspensions were adjusted in the
spectrophotometer (78% transmittance; 600 nm; Coleman
model 35; Bacharach Instrument Co.) to contain 1.0 3 108
CFU/ml and were diluted 105-fold to 103 CFU/ml with 0.14 M
NaCl (6).
A dilution susceptibility test was used to obtain MICs (28).
Since host-derived antimicrobial peptides and their analogs are
sensitive to divalent cation concentration (14), salt concentra-
tion (3, 26), pH, and buffer composition (6, 9, 13), the follow-
ing modifications were necessary to assess antimicrobial activ-
ity. Synthetic peptides were diluted twofold in 100 ml of 0.14 M
NaCl on styrene plates (Immulon 1; Dynatech Laboratories,
Inc., Chantilly, Va.). Then, 0.14 M NaCl with 10.0 mM ZnCl2
(50 ml) was added since the bactericidal activity of SAAP is
strongly dependent upon zinc as a cofactor (6). Finally, bacte-
rial culture (50 ml) was added to each dilution, and the plates
were incubated at 37°C for 120 min. Control wells containing
only 0.14 M NaCl with 2.5 mM ZnCl2 and bacteria were in-
cluded. After incubation, the number of viable bacteria was
determined by culturing 150 ml from each well in triplicate (50
ml/spot) on Trypticase soy agar containing 5% defibrinated
sheep blood and by incubating the plates overnight at 37°C.
MICs (millimolar values) were determined as the highest di-
lutions of peptides showing no growth on blood agar.
Since many antimicrobial peptides are inactivated by serum
components (21–23), it was assumed that a carryover of pep-
tide from the incubation mixture to the blood agar did not
inhibit the growth of organisms surviving incubation in the test
mixture, giving a false sense of killing. To demonstrate this, P.
haemolytica was mixed with 0.14 M NaCl containing 2.5 mM
ZnCl2 or with 0.14 M NaCl containing 2.5 mM ZnCl2 and 0.5
mM H-DDDDDDD-OH. Immediately after mixing (time 0),
the number of viable bacteria was determined by culturing 150
ml from each well in triplicate (50 ml/spot) on Trypticase soy
agar containing 5% defibrinated sheep blood and incubating
the plates overnight at 37°C. P. haemolytica mixed with 0.14 M
NaCl containing 2.5 mM ZnCl2 had an average of 100.3 CFU/
50-ml spot (standard error, 1.9 CFU/50-ml spot; n 5 30 spots)
and P. haemolytica mixed with 0.14 M NaCl containing 2.5 mM
ZnCl2 and 0.5 mM H-DDDDDDD-OH had an average of
101.0 CFU/50-ml spot (standard error, 1.5 CFU/50-ml spot; n 5
30 spots).
To assess eucaryotic cytotoxicity, 100 ml of TAP, SAAP, or
PYL (6.0 mM each) was added to 900 ml of B-lymphocyte
leukemia cells (BL-3; ATCC CRL 8037; 1.1 3 106 cells/ml in
McCoy’s 5A medium with 10% fetal calf serum) and incubated
for 18 h at 37°C with 5% CO2. Propidium iodide (5 mg/ml) was
added, and cell viability was assessed by flow-cytometric anal-
ysis (model XL cytometer; Coulter Corp.).
Activation peptides TAP and PYL inhibited the growth of
bacteria, but neither peptide was cytocidal for BL-3 cells or C.
krusei (Table 1). MICs varied between peptides and among
bacterial species but were comparable to the MIC of SAAP.
Gram-negative bacteria (e.g., P. haemolytica, E. coli, and K.
pneumoniae) sensitive to surfactant-induced killing by normal
serum (5) were more susceptible (MIC range, 0.08 to 0.90 mM
peptide) than gram-positive bacteria (MIC range, 0.94 to 2.67
mM peptide). The MICs of peptide analogs for P. haemolytica
serotype A1 strain 82-25 varied, depending upon the amino
acid composition, from 30 to 200 mM (Table 2), similar to the
variation previously reported with Asp dipeptide-to-heptapep-
tide homopolymers (6). Interestingly, gram-negative bacteria
(e.g., P. aeruginosa and S. marcescens) resistant to surfactant-
induced killing by normal serum (5) were slightly more resis-
tant to all anionic peptides (MIC range, 1.50 to 3.00 mM
peptide). The MICs of anionic peptides were comparable to
those of other vertebrate antimicrobial peptides (3, 8, 11).
Innate extracellular immune mechanisms serve to suppress
or reduce growth after microbial infection until nonspecific
cellular and specific humoral and cellular immune mechanisms
activate. In vivo, the efficacies of anionic peptides will depend
upon the site of peptide release, peptide concentration, avail-
ability of zinc, comixture with serous fluid or plasma, rate of
clearance by lymphatic, circulatory, and urinary systems, deg-
FIG. 1. Sequences of SAAP (6) and similar propeptide sequences found in
other proenzymes and prohormones. TAP, released during the activation of
trypsin (7, 18), is highly conserved throughout a number of animal species (7).
H-ADADDDDDK-OH is part of the activation sequence for the prohormone
precursor of PYL, a peptide isolated from frog (X. laevis) skin (12). Activation of
prococoonase results in the proteolytic removal of a 1.7-kDa coccoonase activa-
tion peptide (CAP), which is thought to be cleaved further into two free Lys’s, a
tetrapeptide, and the heptapeptide shown (10).
TABLE 1. Antimicrobial activity of synthesized anionic
peptide fragments
Organism
MICa of synthetic peptides (mM)
TAPb SAAPc PYLd
P. haemolytica 0.16 (0.01) 0.08 (0.00) 0.23 (0.02)
E. coli 0.90 (0.16) 0.57 (0.11) 0.85 (0.12)
K. pneumoniae 0.85 (0.08) 0.80 (0.21) 0.90 (0.08)
P. aeruginosa 1.50 1.50 1.50
S. marcescens 3.00 1.50 1.50
S. aureus 1.08 (0.11) 0.94 (0.14) 1.80 (0.17)
S. faecalis 2.67 (0.17) 1.16 (0.13) 1.80 (0.17)
C. krusei .2.77 .3.19 .5.11
a MICs followed by parenthetical values are means of six replications (stan-
dard error). MICs without parenthetical values are the results of only one
replication.
b Ovine trypsinogen activation peptide synthesized from the sequence re-
ported by de Haen et al. (7). Sequence, H-VDDDDK-OH; molecular mass,
705.7 Da.
c Respiratory-associated anionic peptide synthesized from the sequence pre-
viously reported (6). Sequence, H-DDDDDDD-OH; molecular mass, 823.6 Da.
d Propeptide fragment of the hormone PYL from frog (X. laevis) skin. Se-
quence, H-ADADDDDDK-OH, starting 6 amino acids from the NH2-terminal
cleavage site for signal peptidase and immediately prior to the 24-amino-acid
sequence for PYL skin (12). Molecular mass, 978.5 Da.
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radation by oligopeptidases, and type and concentration of
microorganisms encountered. For example, the activation of
pancreatic trypsinogen, which is produced by the pancreas
acinar cells, is triggered by an enterokinase secreted from the
brush border of the small intestine (18). TAP cleaved near the
surface of the epithelial cells in the microenvironment of the
mucous layer may act alone or in concert with other locally
secreted defensins (e.g., Paneth cell defensins or cryptdins [20,
24]) to retard localized bacterial infection and invasion. PYL
activation peptide in frog skin may simply add to the antimi-
crobial barrier already present in the skin and mucosal epithe-
lium (17, 29).
In sites with limited circulatory drainage, such as the respi-
ratory tract, SAAP may have more retention time in situ, may
contribute to the anionic microenvironment on alveolar sur-
faces (2), and may be an adjunct to preexisting innate defense
systems (25). Antimicrobial activity was found originally in
pulmonary surfactant, but SAAP may also occur in the epithe-
lial lining fluid or airway surface fluid removed from the lung
by bronchoalveolar lavage. SAAP in the respiratory lining flu-
ids would provide a barrier refractory to microbial infection
and colonization.
The physiology of anionic peptides and charge-neutralizing
propeptide fragments of zymogens has generally been ignored
(18). These propeptide fragments are distinct from plant, in-
sect, and vertebrate antimicrobial peptides (3, 15, 19), contain
hydrophilic and acidic amino acids, are opposite in charge (pI
2.52 to 3.45), and are considerably smaller (,1 kDa) in size. In
this report, we show that anionic propeptide fragments inhibit
the growth of bacteria in vitro and we propose that they have
innate immune functions on mucosal surfaces, in addition to
their charge-neutralizing roles.
We thank Gwen Laird, Ginger Shipp, and Jonathan Seagren for
technical assistance.
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